Code of Standards
Discussion Board
About
IDEA Council
Become a Member
Membership
Become a Member
Our Members
Member Dashboard
Discussion Boards (Members Only)
Chapters
Canada
Central Atlantic
North Atlantic
North Central
South Atlantic
South Central
West
Events
Upcoming Events
Chapter Happenings
CRC 2023
CRC Venue
Register
CRC Exhibitors & Sponsors
CRC Presenters
CRC Schedule
The Leadership Event - August 1 - 3, 2023
Venue
Register
Education
Conference & Webinar Recordings
Town Hall Archive
Sponsored Webinars
Find or Post a Job
Master's Programs - MR & Data Analytics
Insights Podcast Network
IPC Directory
IA Laureates
Education Providers
Naomi Henderson Legacy Award
Resources
Industry Reports
Code of Standards
Benchmarking Surveys
Blue Book Buyer's Guide
Business Impact of Insights
ISO Certification
ISO 20252 Standard (Market Research)
ISO 20252 - Implementation Support
ISO 27001 Standard (Information Security)
Privacy Shield
About the Frameworks
How to Join
Application
Information for EU/Swiss Citizens to file a complaint
Annual Report 2022
Sponsor & Exhibit
Professional Liability Insurance
Model Contracts & Clauses
Insights & Analytics Market Report
Data Integrity Toolkit
Data Integrity Initiative
Data Integrity Initiative Resources
PAIR
Government Affairs
Protecting the Profession
Advocacy Successes
Position Papers
Legal Affairs
Bill Tracker
GDPR Portal
CCPA/CPRA Portal
News & Updates
Articles
Industry News
Register
Login
Membership
Become a Member
Our Members
Member Dashboard
Discussion Boards (Members Only)
Chapters
Canada
Central Atlantic
North Atlantic
North Central
South Atlantic
South Central
West
Events
Upcoming Events
Chapter Happenings
CRC 2023
CRC Venue
Register
CRC Exhibitors & Sponsors
CRC Presenters
CRC Schedule
The Leadership Event - August 1 - 3, 2023
Venue
Register
Education
Conference & Webinar Recordings
Town Hall Archive
Sponsored Webinars
Find or Post a Job
Master's Programs - MR & Data Analytics
Insights Podcast Network
IPC Directory
IA Laureates
Education Providers
Naomi Henderson Legacy Award
Resources
Industry Reports
Code of Standards
Benchmarking Surveys
Blue Book Buyer's Guide
Business Impact of Insights
ISO Certification
ISO 20252 Standard (Market Research)
ISO 20252 - Implementation Support
ISO 27001 Standard (Information Security)
Privacy Shield
About the Frameworks
How to Join
Application
Information for EU/Swiss Citizens to file a complaint
Annual Report 2022
Sponsor & Exhibit
Professional Liability Insurance
Model Contracts & Clauses
Insights & Analytics Market Report
Data Integrity Toolkit
Data Integrity Initiative
Data Integrity Initiative Resources
PAIR
Government Affairs
Protecting the Profession
Advocacy Successes
Position Papers
Legal Affairs
Bill Tracker
GDPR Portal
CCPA/CPRA Portal
News & Updates
Articles
Industry News
Articles
Archive by tag:
eu
Return
22
Mar
New U.S. Health Care Law Contains Huge Victory for Marketing Research
Howard Fienberg
|
22 Mar, 2010
|
sunshine
,
incentives
,
pharmaceutical
|
Government Affairs
|
The new U.S. healthcare law signed by President Obama today includes the Physician Payments Sunshine Act – and an important win for the survey and opinion research profession. Thanks to lobbying by the Marketing Research Association (MRA) and targeted outreach by MRA grassroots volunteers, the Sunshine Act excludes incentive payments for doctors who participate in marketing research projects.
Read More
24
Jan
Research Profession Testifies Before Joint House & Senate Committee Hearing in Minnesota
Howard Fienberg
|
24 Jan, 2010
|
minnesota
,
sunshine
,
incentives
,
pharmaceutical
|
Government Affairs
|
The U.S. survey and research profession testified today before a joint hearing in the Minnesota House and Senate. The Marketing Research Association’s (MRA) Director of Government Affairs, Howard Fienberg, PLC, defended the use of physician incentives in pharmaceutical and medical device manufacturing.
Read More
28
May
Marketing Research Association Victory in Massachusetts
Howard Fienberg
|
28 May, 2009
|
massachusetts
,
pharmaceutical
,
incentives
,
sunshine
|
Government Affairs
|
Today, the Marketing Research Association (MRA) announces victory in its lobbying and grassroots actions to protect research with health care practitioners in Massachusetts. The Massachusetts Department of Health has issued official guidance exempting market research incentives from the application of the state’s new Marketing Code of Conduct for pharmaceutical and medical device manufacturers.
Read More
06
Apr
Massachusetts Passes Regulations Harming Research with Healthcare Practitioners
Howard Fienberg
|
06 Apr, 2009
|
massachusetts
,
pharmaceutical
,
sunshine
,
incentives
|
Government Affairs
|
Recent regulations passed in Massachusetts will severely hurt research with healthcare practitioners. The Marketing Research Association (MRA) is calling for all members of the research profession in Massachusetts to take action now.
Read More
22
Mar
MRA Helps Kill Legislation in Maryland, Mississippi and Rhode Island – Would Have Crippled Research with Health Care Practitioners
Howard Fienberg
|
22 Mar, 2009
|
incentives
,
sunshine
,
pharmaceutical
,
maryland
,
mississippi
,
rhode island
|
Government Affairs
|
MRA scored several recent victories in the ongoing fight against legislation to require public reporting of survey research incentives for health care practitioners or that ban them outright. MRA recently helped to convince legislators in Maryland and Rhode Island to withdraw their bills and helped to defeat legislation in Mississippi.
Read More
02
Mar
MRA Helps Defeat Bill in New Mexico – Would Have Crippled Research with Physicians
Howard Fienberg
|
02 Mar, 2009
|
incentives
,
sunshine
,
New Mexico
,
pharmaceutical
|
Government Affairs
|
The New Mexico State Senate recently defeated a bill which would have required the public reporting of incentives paid to health care professionals for participation in marketing research studies sponsored by pharmaceutical, medical device or medical supply manufacturers.
Read More
30
Jul
Guidelines for Adverse Event Reporting: The Pharmaceutical Market Research Context
Insights Association
|
30 Jul, 2007
|
pharmaceutical
,
data privacy
,
healthcare
|
Government Affairs
|
Pharmaceutical marketing research and data analytics companies should not be required to assume responsibility for formal reporting of adverse events (AEs) uncovered during routine pharmaceutical marketing research and data analytics in the U.S. because:
Read More
Page 2 of 2
First
Previous
1
[2]
Next
Last
Members only Article - Please login to view
Email:
Password:
Login
Remember Login
Create Account
Forgot Password
Popular
Recent
IA Urges U.S. Labor Department to Treat Research Subjects as Independent Contractors
0 Comments
Specific and Measured Restrictions on Non-Compete Agreements Supported by the Insights Association
0 Comments
Congress Demands Transparency from the Census Bureau’s Ask U.S. Panel Project in Final FY23 Omnibus
0 Comments
Removing the Stuffing from Research
0 Comments
Fighting for You: May 2023 Legislative & Regulatory Update
0 Comments
IA Supports Robust Census Funding in FY24
0 Comments
Fighting for You - April 2023 Legislative and Regulatory Update
0 Comments
Data Quality in the Spotlight at IA's Annual Conference
0 Comments
Government Affairs
(121)
Industry News
(1)
Methods & Trends
(3)
Management & Operations
(2)
IPC Feature
(0)
Oklahoma
Accessibility
DC
taste test
Rhode Island
iso 27001
Members Only
robocall
Nebraska
new jersey